Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

82 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epoetin alfa in patients not on chemotherapy - Canadian data.
Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F. Quirt I, et al. Semin Oncol. 2002 Jun;29(3 Suppl 8):75-80. doi: 10.1053/sonc.2002.33538. Semin Oncol. 2002. PMID: 12082658 Clinical Trial.
Epoetin alfa therapy increases hemoglobin levels and improves quality of life in patients with cancer-related anemia who are not receiving chemotherapy and patients with anemia who are receiving chemotherapy.
Quirt I, Robeson C, Lau CY, Kovacs M, Burdette-Radoux S, Dolan S, Tang SC, McKenzie M, Couture F; Canadian Eprex Oncology Study Group. Quirt I, et al. J Clin Oncol. 2001 Nov 1;19(21):4126-34. doi: 10.1200/JCO.2001.19.21.4126. J Clin Oncol. 2001. PMID: 11689580 Clinical Trial.
Epoetin alfa in cancer patients: evidence-based guidelines.
Turner R, Anglin P, Burkes R, Couture F, Evans W, Goss G, Grimshaw R, Melosky B, Paterson A, Quirt I; Canadian Cancer and Anemia Guidelines Development Group. Turner R, et al. Among authors: quirt i. J Pain Symptom Manage. 2001 Nov;22(5):954-65. doi: 10.1016/s0885-3924(01)00357-8. J Pain Symptom Manage. 2001. PMID: 11728799 Free article. Review.
Single-agent interleukin-2 in the treatment of metastatic melanoma.
Petrella T, Quirt I, Verma S, Haynes AE, Charette M, Bak K; Members of the Melanoma Disease Site Group of Cancer Care Ontario's Program in Evidence-Based Care. Petrella T, et al. Among authors: quirt i. Curr Oncol. 2007 Feb;14(1):21-6. doi: 10.3747/co.2007.97. Curr Oncol. 2007. PMID: 17576460 Free PMC article.
82 results